Skip to main content
. 2016 Aug 1;7(37):59877–59891. doi: 10.18632/oncotarget.10979

Figure 3. CTC capture by NanoVelcro Chips coupled with combined use of CA9 and CD147 as capture antigens.

Figure 3

A., B. Comparisons of capture efficiency between combined CA9-/CD147-based and EpCAM-based NanoVelcro Chips for CTC-mimicking Caki-1/Caki-2 renal cancer cells (A) or CTCs in peripheral blood of 10 RCC patients (B). * p<0.05, ** p<0.01, *** p<0.001.